Trademark: 86470085
Status Date
Monday, August 13, 2018
Filing Date
Wednesday, December 3, 2014
Published for Opposition
Tuesday, May 12, 2015
Abandoned Date
Monday, August 13, 2018
1 A protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells
5 Pharmaceutical preparations for the treatment of white blood cell diseases in the form of protein agent termed leukotoxin derived from a bacterium that has specificity for white blood cells
Aug 13, 2018
Abandonment Notice Mailed - No Use Statement Filed
Aug 13, 2018
Abandonment - No Use Statement Filed
Jan 3, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 2, 2018
Extension 5 Granted
Dec 27, 2017
Extension 5 Filed
Jan 2, 2018
Case Assigned To Intent To Use Paralegal
Dec 27, 2017
Teas Extension Received
Jun 30, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2017
Extension 4 Granted
Jun 28, 2017
Extension 4 Filed
Jun 28, 2017
Teas Extension Received
Dec 20, 2016
Notice Of Approval Of Extension Request E-Mailed
Dec 18, 2016
Extension 3 Granted
Dec 1, 2016
Extension 3 Filed
Dec 1, 2016
Teas Extension Received
Jun 28, 2016
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2016
Extension 2 Granted
May 25, 2016
Extension 2 Filed
Jun 25, 2016
Case Assigned To Intent To Use Paralegal
May 25, 2016
Teas Extension Received
Dec 10, 2015
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2015
Extension 1 Granted
Dec 8, 2015
Extension 1 Filed
Dec 8, 2015
Teas Extension Received
Jul 7, 2015
Noa E-Mailed - Sou Required From Applicant
May 12, 2015
Official Gazette Publication Confirmation E-Mailed
May 12, 2015
Published For Opposition
Apr 22, 2015
Notification Of Notice Of Publication E-Mailed
Mar 18, 2015
Approved For Pub - Principal Register
Mar 18, 2015
Assigned To Examiner
Dec 10, 2014
New Application Office Supplied Data Entered In Tram
Dec 6, 2014
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
